Current Infectious Disease Reports

, 10:332

Antiretroviral therapy: When to start and which drugs to use

Article

DOI: 10.1007/s11908-008-0053-4

Cite this article as:
Anderson, A.M.L. & Lennox, J.L. Curr Infect Dis Rep (2008) 10: 332. doi:10.1007/s11908-008-0053-4

Abstract

US guidelines for treating HIV infection now advocate anti-retroviral therapy (ART) for all HIV-infected patients who have CD4+ T-cell counts less than 350 cells/μL. Treatment is recommended for all pregnant women and patients with AIDS-defining illnesses. At least one major guideline recommends ART for all patients with HIV-associated symptoms. Current first-line treatment for ART-naïve individuals consists of a combination of three agents: two nucleoside reverse transcriptase inhibitors plus either one ritonavir-boosted protease inhibitor or one nonnucleoside reverse transcriptase inhibitor (NNRTI). Although first-line therapies for HIV-infection provide excellent rates of virologic control, ART toxicities remain a challenge.

Copyright information

© Current Medicine Group LLC 2008

Authors and Affiliations

  1. 1.Emory University School of MedicineAtlantaUSA